Close

Roth Capital Affirms Aptose Biosciences (APTO) at 'Buy'; Clinical Hold Update Disappointing, But Positives Remain

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. TSLA
2. META
3. ENPH
4. TXN
5. BA
6. SPOT
7. IBM
8. V
9. CMG
10. HCP


Go back to Roth Capital Affirms Aptose Biosciences (APTO) at 'Buy'; Clinical Hold Update Disappointing, But Positives Remain

Form 6-K Aptose Biosciences Inc. For: Oct 13

October 13, 2016 8:31 AM EDT

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of October 2016

Commission File... More